Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia

Blood Adv. 2023 Aug 22;7(16):4319-4322. doi: 10.1182/bloodadvances.2023010099.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents / adverse effects
  • Child
  • Humans
  • Hydroxyurea* / adverse effects

Substances

  • Hydroxyurea
  • Antisickling Agents